Naoyuki Kamatani, MD, PhD
Chief Executive Officer
Naoyuki Kamatani Former Professor at Tokyo Women’s Medical University, former Director of RIKEN Center, engaged in multiple successful new drug developments, over 600 publications including 34 Nature & Nat Genet papers
Hideki Ishihara, PhD
Head of New Drug Development Project
Former head of Novartis Labs, former senior researcher at Sysmex, current technical supervisor at Nittoh
Jun-ichi Kaku
Head of Administration
President, StaGen Inc.